Why It Matters

The AMA’s $4.62 million Q3 2025 lobbying push a rare convergence of legislative opportunities that could reshape physician economics and workforce stability. Congress is simultaneously considering Medicare payment reforms, bipartisan bills to add 14,000 residency slots addressing a projected 86,000-physician shortage, and regulatory changes to prior authorization burdens.

The medical community faces an existential challenge: without payment certainty and workforce expansion, physician shortages will worsen and consolidation will accelerate. The AMA’s strategy leverages a 24-person team with deep congressional ties to secure permanent telehealth flexibilities before September 30 expiration, codify prior authorization reforms, and expand GME funding through Medicare. The window is narrow—several bills are actively advancing through committees—making intensive lobbying essential to shape outcomes affecting physician viability in underserved communities for the next decade.

By the Numbers

The American Medical Association reported $4.62 million in in-house lobbying expenditures for Q3 2025, deploying 24 registered lobbyists. This represents the AMA’s continued reliance on internal advocacy over external firms.

The AMA is a longstanding Washington power player with over $430 million in total reported lobbying expenditures since August 2003. The organization’s in-house operations account for $418.7 million across 77 filings, demonstrating strategic preference for maintaining direct control over messaging.

The lobbying team includes members with substantial Capitol Hill experience. Robert Hamilton Redding served as Legislative Director for Rep. Drew Ferguson (R-GA), while Dana Kristine Lichtenberg spent over 11 years in the House, including work on the Science, Space and Technology Committee. Long-serving veterans like Margaret Danaher Garikes and Jason W. Marino have represented the AMA continuously since 2003 and 2006, respectively.

The Agenda

The American Medical Association is lobbying on ten major healthcare policy areas during Q3 2025. Medicare and Medicaid payment reform tops the agenda, focusing on physician fee schedule adjustments and Medicare Advantage prior authorization practices. The organization is heavily advocating for expanded graduate medical education funding, targeting bipartisan legislation like the Resident Physician Shortage Reduction Act that would add 14,000 residency slots.

Beyond payment and workforce issues, the AMA is lobbying on pharmacy benefit manager transparency, artificial intelligence integration in medical practice, telehealth policy—particularly permanent extensions of pandemic-era flexibilities set to expire—scope of practice regulations for non-physician providers, healthcare system consolidation, foreign medical graduate retention, and medical liability reform.

Broader Context

Congress is advancing on multiple healthcare fronts that directly affect physician interests. Medicare payment reform remains critical as CMS imposed a 2.93% payment reduction for 2025, though for the first time this century, CMS proposed multiple conversion factors for 2026, suggesting potential increases.

Physician workforce expansion enjoys rare bipartisan consensus. Senators introduced the Resident Physician Shortage Reduction Act adding 14,000 Medicare-funded residency positions as the U.S. faces a projected shortage of 86,000 physicians by 2036.

Telehealth policy faces an urgent deadline as pandemic-era flexibilities expire September 30, 2025, while bipartisan bills including the CONNECT for Health Act propose making flexibilities permanent.

Between The Lines

Bipartisan momentum is building despite recent setbacks. The Bipartisan Health Care Act (S.891) includes temporary payment increase provisions, though a House spending bill excluded Medicare physician fee fixes. Rep. Greg Murphy (R-NC) states the pay fix is "back on the agenda," creating an opening for AMA advocacy.

The bipartisan Conrad State 30 and Physician Access Reauthorization Act, championed by Thom Tillis (R-NC) and Amy Klobuchar (D-MN), aligns with AMA goals for retaining foreign medical graduates in underserved areas.

Competitive Landscape

The AMA’s lobbying occurs alongside coordinated advocacy by other major healthcare organizations. The American Osteopathic Association is actively lobbying on Medicare physician payment reform, GME expansion, and prior authorization relief—mirroring the AMA’s agenda. Mass General Brigham is advocating on Medicare provider reimbursement and physician fee schedule protection.

This parallel advocacy indicates a unified provider community effort to influence federal healthcare policy during a legislative window where multiple issues are simultaneously advancing through Congress.

The Bottom Line

The American Medical Association’s $4.62 million Q3 2025 lobbying investment reflects a healthcare policy landscape where multiple physician priorities are simultaneously advancing through Congress. The medical profession’s coordinated lobbying efforts appear strategically timed to influence federal policy on payment structures and workforce development. However, uncertainty remains—the Medicare physician fee schedule path forward remains contested, and scope-of-practice conflicts with non-physician providers continue unresolved at the federal level.

Spot something wrong? Report an issue with this article